Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1997.3598.85 (+5.21 %)

PREV CLOSE ( ) 1898.50

OPEN PRICE ( ) 1898.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11304

TODAY'S LOW / HIGH ( )1898.50 2020.00

52 WK LOW / HIGH ( )1206 2658

NSE1991.2090.3 (+4.75 %)

PREV CLOSE( ) 1900.90

OPEN PRICE ( ) 1905.95

BID PRICE (QTY) 1991.20 (33)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 396104

TODAY'S LOW / HIGH( ) 1905.00 2019.00

52 WK LOW / HIGH ( )1205.45 2664

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984

Management Info

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office

Address 1482-1486 ,Trasad Road,Dholka,
Ahmedabad Dist,
Gujarat-382225

Phone 02714-222604 / 398200

Email complianceofficer@concordbiotech.com

Website www.concordbiotech.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

19Nov Concord Biotech informs about earnings
In continuation of letter dated November 12, 2024 regarding Audio record..

06Nov Concord Biotech informs about earnings
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

06Nov Concord Biotech informs about board me
Concord Biotech has informed that the meeting of the Board of Directors..

25Sep Concord Biotech informs about closure
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015,..

24Sep Concord Biotech informs about clarific
With reference to letter bearing reference no. L/SURV/ONL/PV/AV/2024-202..

Financials

Rs. in Millions

	QTR Sep 24	ANNUAL 24
Net Profit	987	3047.31
Gross Profit	1332.94	4091.93
Operating Profit	1467.04	4653.37
Net Sales	3101.81	10169.39

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Strides Pharma Scien (BSE) 1520.00 (9.16%)	M.Cap ( in Cr)13977.65
Alkem Laboratories (BSE) 5601.00 (1.37%)	M.Cap ( in Cr)66968.36
AMI Organics (BSE) 2093.30 (3.41%)	M.Cap ( in Cr)8568.81
Divi's Lab (BSE) 5960.00 (1.08%)	M.Cap ( in Cr)158219.27
Shilpa Medicare (BSE) 935.80 (6.35%)	M.Cap ( in Cr)9151.27

Shareholding Pattern

	PROMOTERS	44.08%
	NON-INSTITUTION	38%
	MUTUAL FUNDS/UTI	4.97%
	FI/BANKS/INSURANCE	4.3%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	3.84
Edelweiss Recently ...	2.67
Baroda BNP Paribas ...	2.28
Invesco India Multi...	1.93
Invesco India Aggre...	1.80
Union Small Cap Fun...	1.46
Baroda BNP Paribas ...	1.44

Risk Disclosures on Derivatives

Smart Quotes

CONCORD BIOTECH LTD.